The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Measles Is Back. How Does This Affect Patients with Rheumatic Disease?

Measles Is Back. How Does This Affect Patients with Rheumatic Disease?

August 16, 2019 • By Ruth Jessen Hickman, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

phichet chaiyabin / shutterstock.comDespite the presence of a highly effective vaccine, measles (rubeola) is still an important problem worldwide, one that has reemerged in some areas of the world where it had previously been almost eradicated. Rheumatology patients may have questions about whether they are sufficiently protected. Here we discuss key considerations for rheumatologists in light of recent outbreaks.

You Might Also Like
  • Vaccinations for Immunocompromised Patients Are Shared Responsibility of Specialists, Primary Care Physicians
  • ACR/ARHP Annual Meeting 2012: Immunosuppressed Rheumatic Disease Patients Still Candidates for Vaccines
  • Hepatitis Virus, Rheumatic Disease Connection Explored
Explore This Issue
August 2019
Also By This Author
  • Study Explores Palindromic Rheumatism to Predict RA Development

Background

Cassandra Calabrese, DO, trained as a rheumatologist and infectious disease specialist and is affiliated with the Cleveland Clinic. She points out, “The virus can sit in the air in the room where an infected person was and infect people for the next couple of hours. If someone with measles were to walk into a room of 100 unvaccinated people, at least 90 people in that room would get measles.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Because it is so contagious, measles spreads very quickly through unvaccinated populations. Although many people experience no long-lasting problems from the infection, the disease can cause serious complications, including blindness, encephalitis and severe respiratory infections.1

Recent Measles Outbreaks

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Although the trend since the turn of the century has been toward decreased numbers of measles infections, the past few years have seen increased rates worldwide. Almost all parts of the world are showing such increases, with substantial outbreaks in certain countries, including Madagascar, Sudan, Ethiopia, Georgia, Ukraine, Myanmar, the Philippines and Thailand, among others.2

Outbreaks have also been seen in countries with high vaccination rates overall, including the U.S. “Unfortunately, we’ve seen a steady upsurge in the number of measles cases, which for 2019 has exceeded the number of cases we have seen yearly since 1994,” explains Dr. Calabrese. “We’ve had two very large outbreaks in Washington state, which fortunately have been declared over, and other large outbreaks in New York state and New York City. These have been driven both by people coming in from other countries with measles as well as infections in unvaccinated populations that live in the U.S.” In the first seven months of 2019, the Centers for Disease Control & Prevention (CDC) confirmed 1,172 individual cases of measles in 30 U.S. states.3

Kevin Winthrop, MD, MPH, a professor of public health and infectious diseases at Oregon Health and Science University, Portland, says, “When you start dipping below levels of what you need in terms of population vaccine coverage, you put yourself at risk for the disease to reestablish itself.” He also notes, “To have this many endemic cases in the U.S. is quite a wake-up call.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 5 | Single Page

Filed Under: Conditions, Safety Tagged With: immunosuppressive drugs, vaccines, washoutIssue: August 2019

You Might Also Like:
  • Vaccinations for Immunocompromised Patients Are Shared Responsibility of Specialists, Primary Care Physicians
  • ACR/ARHP Annual Meeting 2012: Immunosuppressed Rheumatic Disease Patients Still Candidates for Vaccines
  • Hepatitis Virus, Rheumatic Disease Connection Explored
  • Live Herpes Zoster Vaccine Fails to Provide Long-Term Protection in RA Patients on Tofacitinib

About Ruth Jessen Hickman, MD

Ruth Jessen Hickman, MD, was born and raised in eastern Kentucky, where she first cultivated her love of literature, writing and personal narratives. She attended Kenyon college, where she received a Bachelor of Arts in philosophy, summa cum laude. She worked with individuals with psychiatric conditions and later in a neuroscience lab at the University of Illinois, Chicago, before graduating from Indiana University Medical School in 2011. Instead of pursuing clinical medicine, Ruth opted to build on her strength of clearly explaining medical topics though a career as a freelance medical writer, writing both for lay people and for health professionals. She writes across the biomedical sciences, but holds strong interests in rheumatology, neurology, autoimmune diseases, genetics, and the intersection of broader social, cultural and emotional contexts with biomedical topics. Ruth now lives in Bloomington, Ind., with her husband, son and cat. She can be contacted via her website at ruthjessenhickman.com.

View more by this author»

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.